Skip to main content
. 2023 Sep 14;9(9):e20157. doi: 10.1016/j.heliyon.2023.e20157

Table 1.

Characteristics of participants.

Patient experts (N = 7) Other experts (N = 16)
Country
 European Union 3
 Canada 3
 United Kingdom 7 4
 United States 6
Role
 Regulator 5
 Academic researcher 7
 Payer 1
 Industry expert 3
 Patient 5
 Patient advocate 2
Gender
 Male 5 6
 Female 2 10